118 related articles for article (PubMed ID: 25345853)
1. Inhibitory effect of ethanol extract of Ocimum sanctum on osteopontin mediated metastasis of NCI-H460 non-small cell lung cancer cells.
Kwak TK; Sohn EJ; Kim S; Won G; Choi JU; Jeong K; Jeong M; Kwon OS; Kim SH
BMC Complement Altern Med; 2014 Oct; 14():419. PubMed ID: 25345853
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.
Desai B; Rogers MJ; Chellaiah MA
Mol Cancer; 2007 Mar; 6():18. PubMed ID: 17343740
[TBL] [Abstract][Full Text] [Related]
3. Regulatory roles of osteopontin in human lung cancer cell epithelial-to-mesenchymal transitions and responses.
Shi L; Hou J; Wang L; Fu H; Zhang Y; Song Y; Wang X
Clin Transl Med; 2021 Jul; 11(7):e486. PubMed ID: 34323425
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin promotes ovarian cancer progression and cell survival and increases HIF-1alpha expression through the PI3-K/Akt pathway.
Song G; Cai QF; Mao YB; Ming YL; Bao SD; Ouyang GL
Cancer Sci; 2008 Oct; 99(10):1901-7. PubMed ID: 19016748
[TBL] [Abstract][Full Text] [Related]
5. OPN promotes the aggressiveness of non-small-cell lung cancer cells through the activation of the RON tyrosine kinase.
Hao C; Cui Y; Chang S; Huang J; Birkin E; Hu M; Zhi X; Li W; Zhang L; Cheng S; Jiang WG
Sci Rep; 2019 Dec; 9(1):18101. PubMed ID: 31792339
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin promotes gastric cancer progression
Qin YC; Yan X; Yuan XL; Yu WW; Qu FJ
World J Gastrointest Oncol; 2023 Sep; 15(9):1544-1555. PubMed ID: 37746644
[TBL] [Abstract][Full Text] [Related]
7. Involvement of osteopontin in the matrix-degrading and proangiogenic changes mediated by nicotine in pancreatic cancer cells.
Lazar M; Sullivan J; Chipitsyna G; Gong Q; Ng CY; Salem AF; Aziz T; Witkiewicz A; Denhardt DT; Yeo CJ; Arafat HA
J Gastrointest Surg; 2010 Oct; 14(10):1566-77. PubMed ID: 20824368
[TBL] [Abstract][Full Text] [Related]
8. Fenofibrate suppresses the progression of hepatoma by downregulating osteopontin through inhibiting the PI3K/AKT/Twist pathway.
Chen W; Chen F; Gong M; Ye L; Weng D; Jin Z; Wang J
Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; 397(2):1025-1035. PubMed ID: 37566308
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Erk1/2 activation by osteopontin in PC3 human prostate cancer cells.
Robertson BW; Bonsal L; Chellaiah MA
Mol Cancer; 2010 Sep; 9():260. PubMed ID: 20868520
[TBL] [Abstract][Full Text] [Related]
10. Zerumbone Suppresses Osteopontin-Induced Cell Invasion Through Inhibiting the FAK/AKT/ROCK Pathway in Human Non-Small Cell Lung Cancer A549 Cells.
Kang CG; Lee HJ; Kim SH; Lee EO
J Nat Prod; 2016 Jan; 79(1):156-60. PubMed ID: 26681550
[TBL] [Abstract][Full Text] [Related]
11. The RGD domain of human osteopontin promotes tumor growth and metastasis through activation of survival pathways.
Courter D; Cao H; Kwok S; Kong C; Banh A; Kuo P; Bouley DM; Vice C; Brustugun OT; Denko NC; Koong AC; Giaccia A; Le QT
PLoS One; 2010 Mar; 5(3):e9633. PubMed ID: 20224789
[TBL] [Abstract][Full Text] [Related]
12. Expression pattern of osteopontin isoforms in malignant melanoma cell lines.
Koroknai V; Szász I; Jámbor K; Balázs M
Clin Transl Sci; 2024 Jan; 17(1):e13694. PubMed ID: 38058256
[TBL] [Abstract][Full Text] [Related]
13. Common Variants in Osteopontin and
Gałecki S; Gdowicz-Kłosok A; Deja R; Masłyk B; Giglok M; Suwiński R; Butkiewicz D
Cells; 2023 Nov; 12(23):. PubMed ID: 38067149
[TBL] [Abstract][Full Text] [Related]
14. Deletion of osteopontin in non-small cell lung cancer cells affects bone metabolism by regulating miR-34c/Notch1 axis: a clue to bone metastasis.
Guo J; Tong CY; Shi JG; Li XJ; Chen XQ
Eur J Histochem; 2023 Jul; 67(3):. PubMed ID: 37491944
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin in cancer.
Kumari A; Kashyap D; Garg VK
Adv Clin Chem; 2024; 118():87-110. PubMed ID: 38280808
[TBL] [Abstract][Full Text] [Related]
16. Regulatory roles of Osteopontin in lung epithelial inflammation and epithelial-telocyte interaction.
Fu H; Liu X; Shi L; Wang L; Fang H; Wang X; Song D
Clin Transl Med; 2023 Aug; 13(8):e1381. PubMed ID: 37605313
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin can act as an effector for a germline mutation of BRCA1 in malignant transformation of breast cancer-related cells.
El-Tanani MK; Yuen HF; Shi Z; Platt-Higgins A; Buckley NE; Mullan PB; Harkin DP; Johnston PG; Rudland PS
Cancer Sci; 2010 Jun; 101(6):1354-60. PubMed ID: 20384635
[TBL] [Abstract][Full Text] [Related]
18. A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo.
Dai J; Li B; Shi J; Peng L; Zhang D; Qian W; Hou S; Zhao L; Gao J; Cao Z; Zhao J; Wang H; Guo Y
Cancer Immunol Immunother; 2010 Mar; 59(3):355-66. PubMed ID: 19690854
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol depletion decreases adhesion of non-small cell lung cancer cells to E-selectin.
Mohammadalipour A; Showalter CA; Muturi HT; Farnoud AM; Najjar SM; Burdick MM
Am J Physiol Cell Physiol; 2023 Aug; 325(2):C471-C482. PubMed ID: 37399498
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin regulates the growth and invasion of liver cancer cells via DTL.
Liu Z; Yang G; Yi X; Zhang S; Feng Z; Cui X; Chen F; Yu L
Oncol Lett; 2023 Nov; 26(5):476. PubMed ID: 37809049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]